EBD Group is the leading partnering firm for the global life science industry. Our mission is to facilitate the critical, strategic connections that drive life science dealmaking. We specialize in bringing people together, whether face-to-face at one of our leading global life science partnering events powered by partneringONE, or virtually through our online community of dealmakers and thought-leaders. Over the past two decades, our products and services have grown to become the heart of a highly networked ecosystem of industry collaborators. Our market leading partnering events and digital communities knit together geographically dispersed life science communities to create a thriving, global marketplace of ideas and products.
Bruntwood SciTech, a 50:50 joint venture between Bruntwood and Legal & General, creates the specialist environments and innovation ecosystems that science and technology businesses need to form, scale and grow. With 10 specialist campuses across the UK, Bruntwood SciTech is the UK's leading property provider to the science and tech sector, offering flexible, affordable office and lab space alongside bespoke business support, as standard.
Caszyme is a biotech company, based in Vilnius, Lithuania. The company specializes in development and applications of CRISPR Cas technology and aims to develop new discoveries, innovative applications, and top-quality research in the field of CRISPR-based molecular tools. Caszyme seeks to create an outstanding value for researchers and companies practising gene-editing worldwide.
Different industries and applications that use CRISPR-Cas technology require Cas proteins with different characteristics. Caszyme offers a platform of different CRISPR-based Cas proteins. The company identifies, characterises, and develops these proteins, which are then offered to company clients for applications in human therapeutics, diagnostics, agriculture, research tools, and industrial biotech. Also, based on the needs of a client Caszyme engages in collaborations on identifying and characterizing novel CRISPR-based molecular tools with required specifications.
Charles River provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions around the globe accelerate their research and drug development efforts. Our dedicated employees are focused on providing clients with exactly what they need to improve and expedite the discovery, early-stage development and safe manufacture of new therapies for the patients who need them. To learn more about our unique portfolio and breadth of services, visit www.criver.com.
Evotec is a life science company with a unique business model focused on delivering highly effective new therapeutics to the patients.
The Company leverages its multimodality platform, the “Data-driven R&D Autobahn to Cures”, for proprietary projects and within a network of partners including Pharma, Biotech, academics, and other healthcare stakeholders.
With more than 5,000 highly qualified people at 17 sites, Evotec aims to create the world-leading co-owned pipeline for innovative therapeutics.
Get in touch if you are interested in partnering with us and building the BiotechBikers community.